-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although the benefits of continuous blood glucose monitoring for diabetic patients have been proven before, its benefits have only been fully studied in type 1 diabetic patients or type 2 diabetic patients treated with multiple daily insulin injections (ie, pre-meal insulin)
.
Research author Dr.
Rodica Busui is the vice chair of clinical research in internal medicine at the University of Michigan School of Health.
She said that this work is the first time to thoroughly understand the use of continuous blood glucose monitors to receive only basal insulin therapy (long-acting insulin, one to two injections per day).
Second, to provide adequate insulin levels during the day and night) of poorly controlled type 2 diabetes patients
.
Busui said: "This trial not only demonstrates the benefits of continuous blood glucose monitoring for these patients, this technology has not been used by many insurance companies for patients with type 2 diabetes, and these benefits are available in a wide range of socioeconomic status and ethnic backgrounds.
See
.
" She added that about half of the study participants were ethnic minorities
This randomized clinical trial started recruiting patients from mid-2018 to the end of 2019 and will be followed up in mid-2020
.
Participants received one or two long-acting basal insulin injections a day, regardless of whether they were using non-insulin medications to help lower blood sugar levels
"Without cooperation between endocrinologists and primary care physicians, this work is impossible because all patients are recruited and treated by our primary care team," Busui said
.
In addition to testing the efficacy of continuous blood glucose monitoring and basal insulin among study participants, Busui and her team sought to better understand how the impact of this diabetes treatment method affects patients’ adherence to disease management and their overall life satisfaction
.
To the delight of the researchers, 175 study participants showed better persistence in diabetes management and their life satisfaction was higher
.
Busui said: "The most exciting thing for me is that this study showed that compared with the usual finger stick method, the subjects who randomly used continuous blood glucose monitors significantly improved their blood glucose levels.
It is effective in reducing the risk of hypoglycemia
.
"
"This may open the door to the widespread application of this game-changing technology in all diabetic patients
.
If more patients can use this resource, and their primary care physicians accept the benefits of using this resource for patients Education, then they can control diabetes
With Medicare’s recent announcement that it will remove the requirement for four finger punctures a day to meet the coverage of continuous blood glucose monitors, the future of more affordable health care looks a bit bright
Original Search: Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
